Nanomedicine in Oncology: Targeted Approaches for Improved Chemotherapeutic Efficacy

Nanomedicine has emerged as a transformative field in oncology by offering precise and targeted delivery of chemotherapeutic agents. Nanocarriers such as liposomes, micelles, and polymeric nanoparticles enhance drug accumulation at tumor sites while reducing systemic toxicity. This article reviews current advances in nanomedicine, explores mechanisms of tumor targeting, discusses recent clinical applications, and evaluates challenges related to translation and approval. With continued research and innovation, nanomedicine is poised to become a fundamental component of precision cancer therapy.